Alane P. Barnes's most recent trade in Biocryst Pharmaceuticals Inc. was a trade of 21,773 Common Stock done at an average price of $7.6 . Disclosure was reported to the exchange on Dec. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.65 per share. | 19 Dec 2025 | 21,773 | 398,751 (0%) | 0% | 7.6 | 166,563 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.41 per share. | 19 Dec 2025 | 16,902 | 420,524 (0%) | 0% | 7.4 | 125,244 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 255,050 | 255,050 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 121,700 | 437,426 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.65 per share. | 12 Dec 2025 | 21,210 | 315,726 (0%) | 0% | 7.7 | 162,257 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.57 per share. | 12 Dec 2025 | 8,540 | 336,936 (0%) | 0% | 7.6 | 64,648 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 91,004 | 0 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.10 per share. | 01 Dec 2025 | 91,004 | 416,152 (0%) | 0% | 7.1 | 646,511 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 01 Dec 2025 | 91,004 | 507,156 (0%) | 0% | 3.2 | 293,033 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.21 per share. | 01 Dec 2025 | 50,906 | 365,246 (0%) | 0% | 7.2 | 367,216 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.65 per share. | 01 Dec 2025 | 19,770 | 345,476 (0%) | 0% | 7.7 | 151,241 | Common Stock |